| P50 | author | Lorenzo Piemonti | Q37382584 |
| P2093 | author name string | Valeria Sordi | |
| P2860 | cites work | Donor-derived brain tumor following neural stem cell transplantation in an ataxia telangiectasia patient | Q21090134 |
| | Islet transplantation in seven patients with type 1 diabetes mellitus using a glucocorticoid-free immunosuppressive regimen | Q28141785 |
| | Isolation of putative progenitor endothelial cells for angiogenesis | Q28302884 |
| | Signals from the neural crest regulate beta-cell mass in the pancreas | Q28511170 |
| | Multipotent stromal cells from human marrow home to and promote repair of pancreatic islets and renal glomeruli in diabetic NOD/scid mice. | Q30478228 |
| | Mesenchymal stem cells can be differentiated into endothelial cells in vitro | Q31063600 |
| | Successful islet transplantation: continued insulin reserve provides long-term glycemic control | Q31089312 |
| | Five-year follow-up after clinical islet transplantation | Q33218078 |
| | Detection of 111In-oxine-labeled bone marrow stromal cells after intravenous or intralesional administration in chronic paraplegic rats | Q45275526 |
| | The impact of diabetes mellitus on mortality from all causes and coronary heart disease in women: 20 years of follow-up | Q45303554 |
| | Bone marrow-derived mesenchymal stem cells improve islet graft function in diabetic rats. | Q45958465 |
| | Reduced insulin secretion and content in VEGF-a deficient mouse pancreatic islets | Q46382332 |
| | Hepatocyte growth factor is constitutively produced by donor-derived bone marrow cells and promotes regeneration of pancreatic beta-cells | Q46540500 |
| | Islet transplantation in type 1 diabetes mellitus using cultured islets and steroid-free immunosuppression: Miami experience | Q46582092 |
| | Bone marrow stromal cells can provide a local environment that favors migration and formation of tubular structures of endothelial cells | Q46584311 |
| | Combined islet and hematopoietic stem cell allotransplantation: a clinical pilot trial to induce chimerism and graft tolerance | Q46620610 |
| | Improved metabolic control and quality of life in seven patients with type 1 diabetes following islet after kidney transplantation | Q46687469 |
| | In vitro and in vivo improvement of islet survival following treatment with nerve growth factor. | Q46958656 |
| | Marrow-derived stromal cells express genes encoding a broad spectrum of arteriogenic cytokines and promote in vitro and in vivo arteriogenesis through paracrine mechanisms | Q47248012 |
| | Local delivery of marrow-derived stromal cells augments collateral perfusion through paracrine mechanisms | Q47945142 |
| | Cytogenetic analysis of human bone marrow-derived mesenchymal stem cells passaged in vitro | Q48317427 |
| | Mesenchymal stem cells enhance wound healing through differentiation and angiogenesis. | Q50674319 |
| | Bone marrow (BM) transplantation promotes beta-cell regeneration after acute injury through BM cell mobilization. | Q50700086 |
| | Spontaneous transformation of cultured mouse bone marrow-derived stromal cells. | Q51104088 |
| | The vascular niche and its basement membrane. | Q52674573 |
| | Human bone marrow derived mesenchymal stem cells do not undergo transformation after long-term in vitro culture and do not exhibit telomere maintenance mechanisms. | Q53328521 |
| | Accumulated chromosomal instability in murine bone marrow mesenchymal stem cells leads to malignant transformation. | Q53352599 |
| | International trial of the Edmonton protocol for islet transplantation. | Q54032399 |
| | Pretransplant infusion of mesenchymal stem cells prolongs the survival of a semiallogeneic heart transplant through the generation of regulatory T cells | Q57702376 |
| | Recruitment of Bone Marrow-Derived Endothelial Cells to Sites of Pancreatic -Cell Injury | Q57720869 |
| | Role of vascular endothelial growth factor in bone marrow stromal cell modulation of endothelial cells | Q73099605 |
| | Islet transplantation: a brave new world | Q73581830 |
| | Islet injury induces neurotrophin expression in pancreatic cells and reactive gliosis of peri-islet Schwann cells | Q74351838 |
| | A significant role for histocompatibility in human islet transplantation | Q79955732 |
| | Enhanced epithelial gap closure and increased angiogenesis in wounds of diabetic mice treated with adult murine bone marrow stromal progenitor cells | Q80403767 |
| | High risk of sensitization after failed islet transplantation | Q81227041 |
| | A novel human stem cell coculture system that maintains the survival and function of culture islet-like cell clusters | Q82084196 |
| | Treatment of refractory acute GVHD with third-party MSC expanded in platelet lysate-containing medium | Q82092596 |
| | ISSCR Guidelines for the Clinical Translation of Stem Cells | Q83694599 |
| | Mesenchymal stem cells cooperate with bone marrow cells in therapy of diabetes | Q33302407 |
| | Cellular islet autoimmunity associates with clinical outcome of islet cell transplantation | Q33344421 |
| | Novel cell-free strategy for therapeutic angiogenesis: in vitro generated conditioned medium can replace progenitor cell transplantation | Q33455791 |
| | Co-graft of allogeneic immune regulatory neural stem cells (NPC) and pancreatic islets mediates tolerance, while inducing NPC-derived tumors in mice | Q33570549 |
| | Bone marrow cell cotransplantation with islets improves their vascularization and function. | Q33749301 |
| | Overcoming the challenges now limiting islet transplantation: a sequential, integrated approach | Q34585184 |
| | Associations of diabetes mellitus with total life expectancy and life expectancy with and without cardiovascular disease | Q34636629 |
| | Grafting of human bone marrow stromal cells into spinal cord injury: a comparison of delivery methods. | Q34776506 |
| | Angiomyeloproliferative lesions following autologous stem cell therapy | Q35153218 |
| | Mesenchymal stem cells enhance allogeneic islet engraftment in nonhuman primates | Q35757109 |
| | The therapeutic potential of neural stem cells | Q36500191 |
| | The development of diabetes in E2f1/E2f2 mutant mice reveals important roles for bone marrow-derived cells in preventing islet cell loss | Q36689966 |
| | Allogeneic bone marrow supports human islet beta cell survival and function over six months | Q36690685 |
| | Formation of composite endothelial cell-mesenchymal stem cell islets: a novel approach to promote islet revascularization | Q36842592 |
| | Immunomodulatory properties of mesenchymal stromal cells | Q36896799 |
| | Simultaneous islet and kidney transplantation in seven patients with type 1 diabetes and end-stage renal disease using a glucocorticoid-free immunosuppressive regimen with alemtuzumab induction | Q36906347 |
| | From endothelial to beta cells: insights into pancreatic islet microendothelium | Q37065881 |
| | Primary graft function, metabolic control, and graft survival after islet transplantation | Q37269443 |
| | Trophic molecules derived from human mesenchymal stem cells enhance survival, function, and angiogenesis of isolated islets after transplantation | Q39745012 |
| | Sarcoma derived from cultured mesenchymal stem cells | Q40220522 |
| | Murine but not human mesenchymal stem cells generate osteosarcoma-like lesions in the lung | Q40233552 |
| | IL-6 protects pancreatic islet beta cells from pro-inflammatory cytokines-induced cell death and functional impairment in vitro and in vivo | Q40544239 |
| | Mesenchymal stem cells suppress lymphocyte proliferation in vitro and prolong skin graft survival in vivo | Q40662801 |
| | Mesenchymal stem cells prevent the rejection of fully allogenic islet grafts by the immunosuppressive activity of matrix metalloproteinase-2 and -9 | Q42276892 |
| | Mesenchymal cells appearing in pancreatic tissue culture are bone marrow-derived stem cells with the capacity to improve transplanted islet function | Q42463306 |
| | Regulation of human beta-cell adhesion, motility, and insulin secretion by collagen IV and its receptor alpha1beta1. | Q42469169 |
| | Allosensitization of islet allograft recipients | Q42522778 |
| | VEGF contributes to postnatal neovascularization by mobilizing bone marrow-derived endothelial progenitor cells | Q42677798 |
| | Mesenchymal stem cell and islet co-transplantation promotes graft revascularization and function. | Q43009815 |
| | Mesenchymal stem cells prevent acute rejection and prolong graft function in pancreatic islet transplantation | Q43063268 |
| | Immune modulation of co-transplantation mesenchymal stem cells with islet on T and dendritic cells | Q43067728 |
| | Clinical-grade production of human mesenchymal stromal cells: occurrence of aneuploidy without transformation | Q43208941 |
| | Neural crest stem cells increase beta cell proliferation and improve islet function in co-transplanted murine pancreatic islets. | Q43262810 |
| | Bone marrow as an alternative site for islet transplantation. | Q43272811 |
| | The dynamic in vivo distribution of bone marrow-derived mesenchymal stem cells after infusion. | Q43599448 |
| | Autoantibody response to islet transplantation in type 1 diabetes | Q43778767 |
| | Cell fusion is the principal source of bone-marrow-derived hepatocytes | Q44383220 |
| | Postnatal bone marrow stromal cells elicit a potent VEGF-dependent neoangiogenic response in vivo | Q44401503 |
| | Marginal mass islet transplantation with autologous mesenchymal stem cells promotes long-term islet allograft survival and sustained normoglycemia | Q45023273 |
| | Single-donor, marginal-dose islet transplantation in patients with type 1 diabetes | Q45267369 |
| P433 | issue | 2 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | mesenchymal stem cell | Q1922379 |
| P304 | page(s) | 132-143 | |
| P577 | publication date | 2010-08-10 | |
| P1433 | published in | The review of diabetic studies : RDS | Q26853988 |
| P1476 | title | Mesenchymal stem cells as feeder cells for pancreatic islet transplants | |
| P478 | volume | 7 | |